Lung Cancer Screening with Low Dose CT

Host Dr. Celina Nahyun Jo sits down with Dr. Perry Pickhardt to explore how opportunistic CT screening is transforming routine imaging into a powerful tool for cardiometabolic risk assessment, bone health evaluation, liver disease detection, and body composition analysis. Togethe ... Show More

Dr. Linda Chu speaks with Dr. Eddy Zandee and Dr. Kirk Davis about multidisciplinary expert consensus recommendations aimed at reducing the use of low yield radiographs and improving imaging appropriateness across healthcare settings. They explore which common radiographic exams ... Show More

Dr. Ashwin Singh Parihar sits down with Dr. Louise Emmett to discuss how post-therapy Lutetium-177 PSMA SPECT/CT may help predict overall survival in patients with metastatic castration resistant prostate cancer and shape future treatment decisions. Drawing from the ENZA-p trial ... Show More

Less than 20% of patients eligible for lung cancer screening get screened in the US. A recent study examined whether adults eligible for lung cancer screening engage in screening for other types of cancer. Coauthor Chi-Fu Jeffrey Yang, MD, of Harvard Medical School joins JAMA Dep ... Show More

<p>A VIDEO RECORDING OF THIS INTERVIEW <a href='https://cdn.jwplayer.com/players/oTVn3trC-rmTFgmxB.html'>IS AVAILABLE HERE</a>.</p> <p>Interim results on overall survival in phase 3 of the IMpower010 trial were presented at this year’s meeting of the International Assosciation fo ... Show More

CHEST December 2021, Volume 160, Issue 6 Gerard A. Silvestri, MD, FCCP, and Adam H. Fox, MD, join CHEST Podcast Moderator Dominique Pepper, MD, to discuss the current knowledge and practice of pulmonologists regarding biomarker testing and targeted therapies in advanced non-small ... Show More

Miranda chats with Jonathan and Jeffrey about usual interstitial pneumonia, cystic lung diseases and the increasingly important team role played by the radiologist. Frank and Andrew discuss France, cheese, "the map is not the territory" and speculate on where radiology AI should ... Show More

<p>JAMA Deputy Editor and JAMA Oncology Editor Mary (Nora) L. Disis, MD, speaks with Kimmie Ng, MD, MPH, chair of the meeting's Scientific Program Committee and associate chief of the Division of Gastrointestinal Oncology at Dana-Farber Cancer Institute.<br /> <br /> <strong>Rela ... Show More

For a probing discussion detailing the American Lung Association’s recent 2024 “State of Lung Cancer” report, we are joined by esteemed thoracic medical oncologist Dr. Jacob Sands of Dana-Farber Cancer Institute and Harvard Medical School. Offering insight into actionable targete ... Show More

Dr. Kristen Highland speaks with Drs. Peter Mazzone and Vickram Tejwani about the recent 2024 American Thoracic Society Conference. Topics discussed include exposure-related mutations in non-smokers' lungs, doing better at getting the right people to be screened and new tools in ... Show More

Dr Dana M Chase from the David Geffen School of Medicine at UCLA in Los Angeles, California, discusses select 2023 data sets on the management of ovarian, endometrial and cervical cancers. 

<p>In this episode I cover lung cancer. We also talk in detail about paraneoplastic syndrome.<br/><br/>If you want to follow along with written notes on lung cancer go to <a href='https://zerotofinals.com/medicine/respiratory/lungcancer/'>https://zerotofinals.com/medicine/respira ... Show More